CA2070995A1 - Sonde diagnostique pour la detection du cancer de l'estomac chez les humains - Google Patents

Sonde diagnostique pour la detection du cancer de l'estomac chez les humains

Info

Publication number
CA2070995A1
CA2070995A1 CA002070995A CA2070995A CA2070995A1 CA 2070995 A1 CA2070995 A1 CA 2070995A1 CA 002070995 A CA002070995 A CA 002070995A CA 2070995 A CA2070995 A CA 2070995A CA 2070995 A1 CA2070995 A1 CA 2070995A1
Authority
CA
Canada
Prior art keywords
met gene
gene product
met
antibody
human stomach
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002070995A
Other languages
English (en)
Inventor
Thomas E. Kmiecik
George F. Vande Woude
Stephen D. Showalter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2070995A1 publication Critical patent/CA2070995A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
CA002070995A 1989-12-27 1990-12-19 Sonde diagnostique pour la detection du cancer de l'estomac chez les humains Abandoned CA2070995A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45755689A 1989-12-27 1989-12-27
US457,556 1989-12-27
PCT/US1990/007313 WO1991009974A1 (fr) 1989-12-27 1990-12-19 Sonde de diagnostic servant a detecter les cancers de l'estomac chez l'homme

Publications (1)

Publication Number Publication Date
CA2070995A1 true CA2070995A1 (fr) 1991-06-28

Family

ID=23817186

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002070995A Abandoned CA2070995A1 (fr) 1989-12-27 1990-12-19 Sonde diagnostique pour la detection du cancer de l'estomac chez les humains

Country Status (5)

Country Link
EP (1) EP0507868A4 (fr)
JP (1) JPH05504476A (fr)
AU (1) AU639532B2 (fr)
CA (1) CA2070995A1 (fr)
WO (1) WO1991009974A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673559B1 (en) 1989-12-27 2004-01-06 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Met proto-oncogene and a method for predicting breast cancer progression
EP0584125B1 (fr) * 1991-05-10 1997-07-16 PHARMACIA & UPJOHN S.p.A. Formes tronquees du recepteur de facteur de croissance des hepatocytes
WO1994000764A1 (fr) * 1992-06-26 1994-01-06 THE UNITED STATES OF AMERICA, represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES Proto-oncogene met et procede de prediction de l'evolution du cancer du sein
DE4225569C2 (de) * 1992-08-03 1996-04-25 Max Planck Gesellschaft Verwendung einer Sonde zur Tumordiagnostik oder Tumortherapie
WO2001075169A2 (fr) * 2000-03-30 2001-10-11 Diadexus, Inc. Compositions et methodes correspondantes permettant de diagnostiquer, de surveiller, et de traiter le cancer de l'estomac ainsi que d'en former des images et en controler l'evolution
US20030049645A1 (en) * 2001-02-14 2003-03-13 David Mu Amplified cancer gene hepsin
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
EP1997832A1 (fr) 2007-05-29 2008-12-03 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre la claudine-18 pour le traitement contre le cancer
AU2011226103C1 (en) 2010-03-10 2016-04-28 Genmab A/S Monoclonal antibodies against c-Met
MX369276B (es) 2012-11-13 2019-11-04 Biontech Ag Agentes para tratamiento de enfermedades cancerosas que expresan claudina.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5015568A (en) * 1986-07-09 1991-05-14 The Wistar Institute Diagnostic methods for detecting lymphomas in humans

Also Published As

Publication number Publication date
JPH05504476A (ja) 1993-07-15
EP0507868A4 (en) 1992-11-04
WO1991009974A1 (fr) 1991-07-11
AU7140691A (en) 1991-07-24
EP0507868A1 (fr) 1992-10-14
AU639532B2 (en) 1993-07-29

Similar Documents

Publication Publication Date Title
US5243041A (en) DNA vector with isolated CDNA gene encoding metallopanstimulin
US5589579A (en) Gene sequence and probe for a marker of non-small cell lung carinoma
JP2001513886A (ja) 前立腺ガンの免疫診断のための化合物およびそれらの使用方法
JP2003518920A (ja) 新規なヒト遺伝子および遺伝子発現産物
JPH0728759B2 (ja) 腫瘍形成性の検出方法
US5610018A (en) Substrate for the epidermal growth factor receptor kinase, antibodies thereto and methods of use thereof
AU639532B2 (en) Diagnostic probe for detecting human stomach cancer
EP1964850A2 (fr) Compositions thérapeutiques et diagnostiques du carcinome mammaire et méthodes afférentes
EP0631584A1 (fr) Diagnostic et therapie du cancer
JP4201057B2 (ja) ヒト転移サプレッサー遺伝子ｋａｉｉに由来する試薬を使用する診断方法及び遺伝子療法
US6238861B1 (en) Neurofibromatosis gene
US5688641A (en) Cancer diagnosis using nucleic acid hybridization
US6387697B1 (en) Compositions for treatment and diagnosis of breast cancer and methods for their use
US5942402A (en) Method of detecting and treating cancer
CA1320161C (fr) Gene lie a un recepteur de l'hormone tyroidienne/steroide qui s'exprime mal dans l'epithelioma hepatocellulaire humain et a un recepteur de l'acide retinoide
JP2800850B2 (ja) 新生物形成の検出方法
US5747264A (en) Method of diagnosing and monitoring prostate cancer
WO2003070757A1 (fr) Acide nucleique codant un polypeptide herv-h, utilise dans le diagnostic du cancer colorectal
KR100233208B1 (ko) 림프계암 또는 상피 세포암의 예후 판정에 사용되는 핵의 인단백질
US7883896B2 (en) Marker molecules associated with lung tumors
WO1998005349A1 (fr) Nouveau procede de detection et de traitement du cancer
JP2002506437A (ja) 癌の新規な検出および治療方法
AU2006200373B2 (en) Novel tumor supressor encoding nucleic acid, PTX1, and methods of use thereof
JP2009195236A (ja) 乳癌の免疫療法および診断のための化合物ならびにそれらの使用のための方法
EP1311529A1 (fr) Nouveau suppresseur tumoral codant l'acide nucleique, ptx1, et procedes d'utilisation de ce dernier

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued